ArticleMolecular oncology2017
A mission-oriented approach to cancer in Europe: a joint mission/vision 2030.
Article in Molecular oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.Molecular oncology · 2026Article
- From the creation of the European research area in 2000 to a Mission on cancer in Europe in 2021-lessons learned and implications.Molecular oncology · 2024Article
- Article
- Engaging European society at the forefront of cancer research and care: How discussions at the 5Molecular oncology · 2023Article
- Palliative oncology and palliative care.Molecular oncology · 2022Article
- Utilization of radiation therapy and predictors of noncompliance among Syrian refugees in Turkey.BMC cancer · 2022Article
- In the spotlight: Julio Celis, the Founding Editor of Molecular Oncology.Molecular oncology · 2022Article
- The Porto European Cancer Research Summit 2021.Molecular oncology · 2021Article
- Towards a cancer mission in Horizon Europe: recommendations.Molecular oncology · 2020Article
- Radiation Oncology - Towards a mission-oriented approach to cancer.Molecular oncology · 2020Article
- Provision and use of radiotherapy in Europe.Molecular oncology · 2020Review
- Do oncology researchers adhere to reproducible and transparent principles? A cross-sectional survey of published oncology literature.BMJ open · 2019Article
- Towards a Cancer Mission in Horizon Europe.Molecular oncology · 2019Article
- Boosting the social impact of innovative cancer research - towards a mission-oriented approach to cancer.Molecular oncology · 2019Article
- German Cancer Consortium (DKTK) - A national consortium for translational cancer research.Molecular oncology · 2019Review
- Late translational research: putting forward a new model for developing new anti-cancer treatments that addresses the needs of patients and society.Molecular oncology · 2019Review
- Bridging research and clinical care - the comprehensive cancer centre.Molecular oncology · 2019Review
- Quality-assured research environments for translational cancer research.Molecular oncology · 2019Review
- Translational cancer research - a coherent cancer research continuum.Molecular oncology · 2019Review
- The European Cancer Patient Coalition and its central role in connecting stakeholders to advance patient-centric solutions in the mission on cancer.Molecular oncology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
By combining innovative prevention and treatment strategies in a sustainable state-of-the-art virtual European cancer centre/infrastructure, it will be possible by 2030 to achieve a long-term survival of 3 out of 4 cancer patients in countries with well-developed healthcare systems. Furthermore, the proposed concerted actions will pave the way to handling the economic and social inequalities in countries with less developed systems. These efforts will also ensure that in the long-run, science-driven and social innovations reach patients across the healthcare systems in Europe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.